Cannabis Law Report

AUGUST 19, 2019

There have been more than 7,500 approvals for medicinal cannabis in Australia since legalisation in 2016 – so why don’t we know if it is helping patients? Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Bringing together our vast portfolio of new proprietary ligands with Beckley Psytech’s clinical capabilities brings obvious synergies.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. In lockstep with the FDA’s more open-minded approach toward psychedelic medicine, Denver, Oakland, and Santa Cruz all decided to decriminalize magic mushrooms.

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Cannabis Law Report

MAY 31, 2022

The first path, that of traditional medicine, currently offers patients limited options. The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. On March 5, 2019, the U.S. Active FDA Regulated Clinical Trials*.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

DECEMBER 9, 2021

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

APRIL 8, 2019

PUBLISHER: CANNABIS LAW REPORT. Through the Narcotic Drugs Amendment Act 2016 (Cth) and its amendments to the Narcotic Drugs Act 1967 (Cth) ( NDA ), the Australian Government commenced the legalisation of medicinal cannabis products in Australia under federal law in 2016. Josh Hunt – Partner. Chapter 2 of the NDA.

Medicine 71

Medicine Research and Development Business Cannabis 71

Cannabis Law Report

AUGUST 21, 2019

PUBLISHER: CANNABIS LAW REPORT. Cannabis treatments are too expensive and do not come with enough test evidence to be effective, UK authorities have said. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works. AUTHOR: Mark Taylor.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

The Cannigma

FEBRUARY 2, 2021

This article was originally published on Analytical Cannabis and appears here with permission. . In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. Of these consumers, over half said the drug had a beneficial clinical effect on their condition.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

AUGUST 5, 2021

Although the overarching market is still relatively new, much like the cannabis boom a few years ago the psychedelics space is growing at an unprecedented rate. billion in 2019. Based out of Vancouver, BC Filament Health aims to treat mental health conditions through the discovery and delivery of pure natural psychedelic medicines.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

SpeedWeed

MARCH 30, 2021

THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. The development has been welcomed and comes as the nation’s doctors are said to be shifting their cultural stance from viewing ‘cannabis as a dirty word’.

Data 52

Data Patients Clinical Trials Business 52

The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. People want to trust their doctors, but doctors need knowledge.

Education 101

Education Clinical Trials Medicine Policy 101

Veriheal

MARCH 23, 2023

The people of Japan, a country renowned for its sushi cuisine scene, iconic Mount Fuji, and eye-catching cherry blossom trees, may soon have access to legal medicinal marijuana for intractable diseases. One of the proposed bills would amend the Cannabis Control Law during the current 150-day Diet session, which launched on Monday, January 23.

Legalization 66

Legalization Marijuana Clinical Trials Seed-To-Sale 66

Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Ohio became the 25th state to legalize medical cannabis back on June 8 of 2016. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Cannabis Law Report

DECEMBER 14, 2019

Investing in cannabis stocks on the ASX: Risks and benefits for ASX pot stocks. Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. million in the Melbourne cannabis firm in 2018. Writes Investing News.com.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

The Cannigma

SEPTEMBER 21, 2021

In the world of cannabis, not everyone can be Snoop, Seth Rogen, or Willie Nelson. There are cannabis users, patients, and just everyday fans who may be fans, but don’t make it a big part of their public persona. I also take a chewy (cannabis pill) at bedtime and this has really helped, too.”. 1) Patrick Stewart. 3) Steve Kerr.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

Cannabis Law Report

NOVEMBER 16, 2019

Current barriers to patient access to medicinal cannabis in Australia. On 14 November 2019, the Senate referred an inquiry into the current barriers to patient access to medicinal cannabis in Australia to the Senate Community Affairs References Committee for inquiry and report by 12 February 2020.

Clinical Trials 58

Clinical Trials Access Medicine Patients 58

The Cannigma

AUGUST 26, 2021

Australia has a legal medical marijuana program, and while recreational cannabis remains illegal on the federal level, the enforcement of cannabis laws and the penalties handed out can differ widely from one territory to another. This also means that the TGA has not accessed these medicines for their safety, quality, or effectiveness.

Legalization 52

Legalization Access Medicine Clinical Trials 52

Cannabis Law Report

DECEMBER 7, 2021

06, 2021 (GLOBE NEWSWIRE) — South Africa’s Cannabis Holdings Group Labat Africa Limited, has listed its shares as a dual listing on the Frankfurt Stock Exchange (FSE). It comes off the back of Germany’s new coalition government planning to legalize cannabis for medicinal and recreational purposes.

Clinical Trials 52

Clinical Trials Medicine Cannabis Pharmaceutical 52

Cannabis Law Report

MAY 29, 2022

In May 2021, a Nature Medicine study showed the benefits of MDMA in relieving post-traumatic stress disorder. [4] 4] In April 2021, a separate study from the New England Journal of Medicine demonstrated the efficacy of psilocybin in reducing symptoms of depression. [5] Clinical Trials and Human Subject Protections.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 9, 2021

In a typical scenario, psychedelic substances would be used in conjunction with psychotherapy sessions to treat disorders for which other medicinal therapies have failed. Denver, Colorado was the first jurisdiction to decriminalize the use of psilocybin via ballot initiative in May 2019. 30, 2019), available at [link].

Law 105

Law Therapy Clinical Trials Research and Development 105

Cannabis Law Report

JULY 4, 2019

The manuscript is part of EMMAC’s collaboration with Imperial College London, forged to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. About EMMAC.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

The Joint Blog

JANUARY 23, 2020

The study is titled “Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.” ” “Medicinal cannabis has received increased research attention over recent years due to loosening global regulatory changes”, states the study’s abstract.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

Cannabis Law Report

JULY 15, 2019

PUBLISHER: CANNABIS LAW REPORT. July 18 marks the first anniversary of the Portuguese medical cannabis law. The major merit of Decree Law 8/2019 was to provide a clear distinction between cannabis-based medicinal products, cannabis-based preparations and cannabis-based substances (dried flower and oils).

Medicine 40

Medicine Clinical Trials Patients Access 40

Healer

MARCH 26, 2021

Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. March 19, 2021.

Chronic Pain 86

Chronic Pain Clinical Trials Treatment Patients 86

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? Veterans can expect to find conflicting information regarding the efficacy of cannabis for their PTSD.

Treatment 104

Treatment Sleep Clinical Trials Data 104

The Joint Blog

FEBRUARY 24, 2021

For decades cannabis researchers have been investigating the impact cannabis has on neurological diseases. Numerous trials have been run using medical marijuana and CBD tinctures to treat or reduce the symptoms of Parkinson’s Disease. This is not the first medicinal trial of its kind. This trial was to take 3.5

Treatment 55

Treatment Clinical Trials Collective Patients 55

Cannabis Law Report

FEBRUARY 28, 2022

Clinical trials are producing promising results, creating enthusiasm for commercializing and patenting psychedelics. 12, 2019), [link] [ [link] ]. Except for ketamine, an essential medicine used in anesthesia, 6 × 6. 10, 2019), [link] [ [link] ]. 26, 2019, 4:07 PM), [link] [ [link] ]. Quibell et al.,

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

JULY 4, 2021

CLR contributor, Brian Cusack, writes… The legalization of cannabis in Ireland has become a popular discussion around the world. While countries like Canada, Uruguay, and some states in America have legalized recreational cannabis, this isn’t a trend that has reached Ireland yet. or none at all to qualify with legal status.

THC 105

THC CBD Legalization Oil 105

Cannabis Law Report

OCTOBER 17, 2019

The introduction of these protocols will take the form of clinical trials and research that will include the usage of specific strains of cannabis that aid in chronic pain and cancer treatments. Tree of Knowledge will be introducing chronic pain management protocols and research into the Caribbean market.

Clinical Trials 40

Clinical Trials Research and Development Chronic Pain CBD 40

Cannabis Law Report

DECEMBER 11, 2021

Since Thailand launched its first cannabis clinic in August 2019, the Public Health Ministry has opened over 500 more nationwide. The facilities are overseen by the Ministry’s Department of Thai Traditional and Alternative Medicine. Can you elaborate on the cannabis oil treatment available at these clinics?

Oil 52

Oil Blood Pressure Concentrates Patients 52

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. Doctors can prescribe Epidyolex – an oral solution of cannabidiol, which comes from the cannabis plant – if they think it will help sufferers. What is Epidyolex?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JUNE 25, 2021

In April 2019, Bristol-Myers Squibb acquired Celgene for $74 billion. The European Medicines Agency (EMA) is the regulatory body that evaluates and supervises the production and sales of medicines for safety and benefit of the customer, in the European Union Region. Cannabis Science Inc. GlaxoSmithKline PLC. Pfizer Inc.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

CannaTech

MARCH 24, 2019

Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. Some of the most recognized applications of cannabinoid-based medicine are in the treatment of neuropathic pain , inflammation and muscle spasticity. These attitudes, however, are changing.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study. “The

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98